Estrogen and progestin use and the QT interval in postmenopausal women

Annals of Noninvasive Electrocardiology

Volumn 9, Issue 4, 2004, Pages 366-374

  Kadish, Alan H ^a,g   Greenland, Philip ^b   Limacher, Marian C ^c   Frishman, William H ^d   Daugherty, Sandra A ^e   Schwartz, Janice B ^f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF NEVADA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Feinberg Pavilion   (United States)

Author keywords

Electrocardiology; Sex hormones

Indexed keywords

ESTROGEN; GESTAGEN; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; COVARIANCE; DRUG EFFECT; DRUG USE; ELECTROCARDIOGRAPHY; ESTROGEN THERAPY; FEMALE; HEART RATE; HEART REPOLARIZATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; QT INTERVAL; UNITED STATES;

ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS;

EID: 9144263646     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2004.94580.x     Document Type: Article

References (27)

1. Bazett H. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-370.
2. Ashman R. Essentials of electrocardiography. New York, Macmillian, 1945.
3. Goldberg RJ, Bengtson J, Chen ZY, et al. Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol 1991;67:55-58.
4. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992;8:690-695.
5. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-2597.
6. Larsen JA, Tung RH, Sadananda R, et al. Effects of hormone replacement therapy on QT interval. Am J Cardiol 1998;82:993-995.
7. Kadish AH, Larsen JA. Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol 1998;9:655-664.
8. Prinzmental M, Nakashima M, Oishi H, et al. Estrogens and the heart. Am J Obstet Gynecol 1967;1967:575-576.
9. Gimeno A, Webb J. Action of sex steriods on the electrical and mechanical properties of rat atrium. Am J Physiol 1963;1963:198-200.
10. Burke JH, Ehlert FA, Kruse JT, et al. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997;79:178-181.
11. Knollman B, Franz M. Acute effects of 17 B estradiol and dihydrotestosterone on action potential duration and QY-interval in isolated rabbit hearts. J Investig Med 1996;44:209A.
12. Drici MD, Burklow TR, Haridasse V, et al. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996;94:1471-1474.
13. Pham TV, Sosunov EA, Anyukhovsky EP, et al. Testosterone diminishes the proarrhythmic effects of dofetilide in normal female rabbits. Circulation 2002;106:2132-2136.
14. Shuba YM. Testosterone-mediated modulation of HERG blockade by proarrhythmic agents. Biochem Pharmacol 2001;62:41-49.
15. Bidoggia H, Maciel JP, Capalozza N, et al. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J 2000;140:678-683.
16. Prentice R, Rossouw JE, Johnson S, et al. The Role of randomized controlled trials in assessing the benefits and risks of long-term hormone replacement therapy: example of the women's health initiative. Menopause: JN Am Menopause Soc 1996;3:71-76.
17. Investigators WGftWsHI. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-333.
18. Rautaharju PM, Park LP, Chaitman BR, et al. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol 1998;31:157-187.
19. Mayuga KA, Parker M, Sukthanker ND, et al. Effects of age and gender on the QT response to exercise. Am J Cardiol 2001;87:163-167.
20. Stramba-Badiale M, Locati EH, Martinelli A, et al. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 1997;18:1000-1006.
21. Sagie A. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992;70:797-801.
22. Rodriguez I. Drug-induced QT prolongation in women during the menstrual cycle. JAMA 2001;285:1322-1326.
23. Challapalli S, Lingamneni R, Horvath G, et al. Twelve-leadQT dispersion is smaller in women then in men. Noninvasive Electrophysiol 1998;3:25-31.
24. Haseroth K. Effects of progestin-estrogen replacement therapy on QT-dispersion in postmenopausal women. Int J Cardiol 2000;75:161-165; discussion 165-166.
25. C dispersion in postmenopausal women with coronary artery disease. Pacing Clin Electrophysiol 1998;21:2392-2395.
26. Bidoggia H, Maciel JP, Capalozza N, et al. Sex-dependent electrocardiographic pattern of cardiac repolarization. Am Heart J 2000;140:430-436.
27. Wolbrette D. Gender differences in the proarrhythmic potential of QT-prolonging drugs. Curr Women Health Rep 2002;2:105-109.